Glaxo stirs AIDS storm in Africa
In the midst of the wrenching international debate over how to get expensive HIV drugs into Africa, pharmaceutical giant Glaxo Wellcome PLC has set off a new controversy by trying to block access to
In the midst of the wrenching international debate over how to get expensive HIV drugs into Africa, pharmaceutical giant Glaxo Wellcome PLC has set off a new controversy by trying to block access to